Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients

被引:3
|
作者
Feng, Jian [1 ,2 ]
Liang, Bin [2 ]
Zhang, Hang-Yu [2 ]
Liu, Zhe [2 ]
Jiang, Kai [2 ]
Zhao, Xiang-Qian [2 ,3 ]
机构
[1] Peking Univ, Dept Hepatopancreatobiliary Surg, Shougang Hosp, Beijing 100144, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Inst Hepatobiliary Surg Chinese PLA, Fac Hepatopancreato Biliary Surg, Key Lab Digital Hepatobiliary Surg, Beijing 100853, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Inst Hepatobiliary Surg Chinese PLA, Fac Hepatopancreato Biliary Surg, Key Lab Digital Hepatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China
来源
关键词
Intrahepatic cholangiocarcinoma; Mass-forming; Treatment; Prognosis; HEPATITIS-B-VIRUS; SURVIVAL RATE; SURGERY; OUTCOMES;
D O I
10.4240/wjgs.v14.i5.442
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer in humans after hepatocellular carcinoma and a rare epithelial malignancy that results in a poor prognosis. According to the Liver Cancer Study Group of Japan classification, ICC can be divided into three types: Mass-forming (MF) type, periductal-infiltrating (PI) type, and intraductal-growth type. The MF type is the most common, accounting for 57.1-83.6% of ICCs. Nevertheless, little is known about the epidemiology and treatment of MF ICC. AIM To examine the prognostic factors for patients with MF ICC. METHODS We carried out a retrospective analysis of consecutive patients with MF ICC treated at the Faculty of Hepato-Pancreato-Biliary Surgery of Chinese PLA General Hospital between January 2008 and December 2018. According to the treatment received, the patients were divided into either a resection group or an exploration group. RESULTS The pooled 1-, 3-, and 5-year survival rates in the 68 patients with MF ICC were 66.5%, 36.3%, and 9.3%, respectively. Univariate analysis revealed that surgical resection (P < 0.001), nodal metastasis (P < 0.001), tumor location (P = 0.039), vascular invasion (P < 0.001), ascites (P < 0.001), and differentiation (P = 0.009) were significantly associated with the prognosis and survival of MF ICC. Multivariate analysis revealed that ascites (hazard ratio [HR] = 5.6, 95% confidence interval [CI]: 1.6-18.9, P = 0.006) and vascular invasion (HR = 2.5, 95%CI: 1.0-6.1, P = 0.045) were independent risk factors for MF ICC. The pooled 1-, 3-, and 5-year survival rates in the 19 patients of the exploration group were 5.3%, 5.3%, and 0, respectively. Among the 49 patients who underwent surgical resection, the pooled 1-, 3-, and 5-year survival rates were 93.5%, 49.7%, and 14.4%, respectively. Univariate and multivariate analyses revealed that vascular invasion (HR = 3.1, 95%CI: 1.2-8.5, P = 0.024) and nodal metastasis (HR = 3.2, 95%CI: 1.4-7.6, P = 0.008) were independent prognostic risk factors for surgical resection patients. CONCLUSION The prognosis of MF ICC patients is dismal, especially those with ascites or vascular invasion. Surgical resection is a key factor in improving overall survival in patients with MF ICC, and vascular invasion and lymph node metastasis affect the efficacy of surgical resection.
引用
收藏
页码:442 / 451
页数:10
相关论文
共 50 条
  • [21] Late recurrence after resection of mass-forming intrahepatic cholangiocarcinoma: report of a case
    Kondo, Naoko Iwahashi
    Shirabe, Ken
    Mano, Yohei
    Taketomi, Akinobu
    Yoshizumi, Tomoharu
    Ikegami, Toru
    Masuda, Toshiro
    Kayashima, Hiroto
    Hashimoto, Naotaka
    Morita, Kazutoyo
    Matsuo, Mizue
    Maehara, Yoshihiko
    [J]. SURGERY TODAY, 2012, 42 (12) : 1210 - 1214
  • [22] MASS-FORMING INTRAHEPATIC CHOLANGIOCARCINOMA PRESENTING WITH PAINFUL OBSTRUCTIVE HEMOBILIA
    Coulier, B.
    Maldague, Ph
    Ramboux, A.
    Gielen, I.
    [J]. JBR-BTR, 2014, 97 (06): : 366 - 369
  • [23] Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma
    Kinoshita, Masahiko
    Kanazawa, Akishige
    Takemura, Shigekazu
    Tanaka, Shogo
    Kodai, Shintaro
    Shinkawa, Hiroji
    Shimizu, Sadatoshi
    Murata, Akihiro
    Nishio, Kohei
    Hamano, Genya
    Ito, Tokuji
    Tsukamoto, Tadashi
    Kubo, Shoji
    [J]. ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 2020, 13 (01) : 46 - 58
  • [24] CLINICOPATHOLOGICAL SPECTRUM OF RESECTED EXTRADUCTAL MASS-FORMING INTRAHEPATIC CHOLANGIOCARCINOMA
    YAMANAKA, N
    OKAMOTO, E
    ANDO, T
    ORIYAMA, T
    FUJIMOTO, J
    FURUKAWA, K
    TANAKA, T
    TANAKA, W
    NISHIGAMI, T
    [J]. CANCER, 1995, 76 (12) : 2449 - 2456
  • [25] Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma
    Uenishi, T
    Yamazaki, O
    Yamamoto, T
    Hirohashi, K
    Tanaka, H
    Tanaka, S
    Hai, S
    Kubo, S
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2005, 12 (06): : 479 - 483
  • [26] Translating imaging traits of mass-forming intrahepatic cholangiocarcinoma into the clinic: From prognostic to therapeutic insights
    Ji, Gu-Wei
    Xu, Qing
    Jiao, Chen-Yu
    Lu, Ming
    Xu, Zheng-Gang
    Zhang, Biao
    Yang, Yue
    Wang, Ke
    Li, Xiang-Cheng
    Wang, Xue-Hao
    [J]. JHEP REPORTS, 2023, 5 (10)
  • [27] Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma
    Rhee, Hyungjin
    Choi, Sang Hyun
    Park, Ji Hoon
    Cho, Eun-Suk
    Yeom, Suk-Keu
    Park, Sumi
    Han, Kyunghwa
    Lee, Seung Soo
    Park, Mi-Suk
    [J]. LIVER INTERNATIONAL, 2022, 42 (04) : 930 - 941
  • [28] Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma
    Asayama, Y
    Yoshimitsu, K
    Irie, H
    Tajima, T
    Nishie, A
    Hirakawa, M
    Nakayama, T
    Kakihara, D
    Taketomi, A
    Aishima, S
    Honda, H
    [J]. RADIOLOGY, 2006, 238 (01) : 150 - 155
  • [29] Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI
    Jieun Koh
    Yong Eun Chung
    Ji Hae Nahm
    Ha Yan Kim
    Kyung-Sik Kim
    Young Nyun Park
    Myeong-Jin Kim
    Jin-Young Choi
    [J]. European Radiology, 2016, 26 : 407 - 416
  • [30] Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI
    Koh, Jieun
    Chung, Yong Eun
    Nahm, Ji Hae
    Kim, Ha Yan
    Kim, Kyung-Sik
    Park, Young Nyun
    Kim, Myeong-Jin
    Choi, Jin-Young
    [J]. EUROPEAN RADIOLOGY, 2016, 26 (02) : 407 - 416